
Loading, please wait...

Loading, please wait...

The India medical device industry is currently undergoing a massive transformation. According to a recent report by Rubix Industry Insights, the sector will likely reach a valuation of USD 50.1 billion by 2030. This growth represents an impressive compound annual growth rate (CAGR) of 26.9 per cent from its 2025 valuation of USD 15.2 billion. Consequently, India remains a pivotal player, currently ranking as the fourth-largest market in Asia and holding a spot among the top 20 globally.
Several factors are driving this rapid expansion across the country. Primarily, rising income levels and expanding health insurance penetration are boosting demand. Furthermore, the growth of medical tourism and increasing healthcare infrastructure provide a solid foundation for both affordable and advanced solutions. However, the sector still faces a significant trade imbalance that requires strategic intervention. Such growth demands a shift toward domestic self-reliance.
Currently, the industry remains largely import-dependent. Approximately 70-80% of domestic demand is met through imports, especially for technologically advanced devices. For instance, electro-medical equipment accounts for nearly 60% of imports. In contrast, India shows immense strength in consumables, which make up 47% of its exports. Therefore, the government aims to raise India's global market share from 1.6% to approximately 12% in the coming years.
Government initiatives play a critical role in strengthening the domestic manufacturing base. Programs like the National Medical Devices Policy (NMDP) and the Production-Linked Incentive (PLI) Scheme provide essential support. Additionally, the MedTech Mitra and the Scheme for Promotion of Medical Devices Parks are fostering innovation. These policies aim to reduce reliance on imports and improve price competitiveness for local manufacturers. This ecosystem encourages high-tech development.
Geographically, four states are leading this industrial evolution. Uttar Pradesh, Maharashtra, Haryana, and Karnataka are strengthening the ecosystem by providing shared infrastructure. Moreover, these states offer skilled manpower and robust supplier networks. This environment specifically helps small and mid-sized manufacturers scale their production efficiently. Consequently, private equity and venture capital funding have also seen a massive 2.5-fold increase in average deal size since 2022.
Q1: What is the expected market size of the Indian medical device sector by 2030?
The industry is projected to reach USD 50.1 billion by 2030, growing at a CAGR of 26.9 per cent from USD 15.2 billion in 2025.
Q2: Which government schemes are supporting the medical device industry in India?
Key initiatives include the National Medical Devices Policy (NMDP), the Production-Linked Incentive (PLI) Scheme, and MedTech Mitra.
Q3: Which states are major hubs for medical device manufacturing in India?
Uttar Pradesh, Maharashtra, Haryana, and Karnataka are the leading states contributing to the industry's infrastructure and skilled workforce.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India's medical device industry is projected to reach $50.1 billion by 2030, supported by government initiatives like NMDP and PLI schemes for manufacturing...
5 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today